Ovid Therapeutics Inc. buy BiotechBee
Start price
14.12.24
/
50%
€0.95
Target price
30.11.26
€3.00
Performance (%)
-69.10%
End price
30.03.25
€0.29
Summary
This prediction ended on 30.03.25 with a price of €0.29. Massive losses of -69.10% were the result for the BUY prediction by BiotechBee. BiotechBee has a follow-up prediction for Ovid Therapeutics Inc. where he still thinks Ovid Therapeutics Inc. is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ovid Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
According to BiotechBee what are the pros and cons of Ovid Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ovid Therapeutics Inc. diskutieren
In the thread Trading Ovid Therapeutics Inc.
Current prediction by BiotechBee for Ovid Therapeutics Inc.
Ovid Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.50
28.09.25
28.09.25
€5.00
30.09.27
30.09.27
-23.33%
18.12.25
18.12.25
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Ovid Therapeutics Inc.
Ovid Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.50
20.07.25
20.07.25
€2.00
20.07.26
20.07.26
118.00%
29.08.25
29.08.25
Could be very worthwhile Investment >20% year